Evidence map›Paper›PMID 33976132›Full record

ArticleNature communications2021

The impact of stopping and starting indoor residual spraying on malaria burden in Uganda.

Jane F Namuganga, Adrienne Epstein, Joaniter I Nankabirwa, Arthur Mpimbaza, Moses Kiggundu, Asadu Sserwanga, James Kapisi, Emmanuel Arinaitwe, Samuel Gonahasa, Jimmy Opigo and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jane F Namuganga *Infectious Diseases Research Collaboration, Kampala, Uganda.
Adrienne Epstein *Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. Adrienne.Epstein@ucsf.edu.ORCID 0000-0002-8253-6102
Joaniter I NankabirwaInfectious Diseases Research Collaboration, Kampala, Uganda.
Arthur MpimbazaInfectious Diseases Research Collaboration, Kampala, Uganda.
Moses KiggunduInfectious Diseases Research Collaboration, Kampala, Uganda.
Asadu SserwangaInfectious Diseases Research Collaboration, Kampala, Uganda.
James KapisiInfectious Diseases Research Collaboration, Kampala, Uganda.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
Samuel GonahasaInfectious Diseases Research Collaboration, Kampala, Uganda.
Jimmy OpigoNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Chris EbongInfectious Diseases Research Collaboration, Kampala, Uganda.
Sarah G StaedkeLondon School of Hygiene and Tropical Medicine, London, UK.
Josephat ShililuUS President's Malaria Initiative - VectorLink Uganda Project, Kampala, Uganda.
Michael OkiaUS President's Malaria Initiative - VectorLink Uganda Project, Kampala, Uganda.
Damian RutazaanaNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Catherine Maiteki-SebuguziNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Kassahun BelayUS President's Malaria Initiative, USAID/Uganda Senior Malaria Advisor, Kampala, Uganda.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Grant DorseyDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Isabel Rodriguez-BarraquerDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
Training in malaria surveillance, epidemiology and implementation science research to strengthen malaria policy and control in UgandaD43TW010526 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2017 to 2026
$2.3M
Impact of malaria control interventions on the infectious reservoir, host immunity, and drug resistance in UgandaK43TW010365 · FIC · INFECTIOUS DISEASES RES COLLABORATION · PI NANKABIRWA, JOANITER IMMACULATE · 2017 to 2021
$514k
Mapping malaria incidence using health facility surveillance data in UgandaF31AI150029 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPSTEIN, ADRIENNE · 2020 to 2021
$59k
FIC NIH HHS D43 TW010526FIC NIH HHS K43 TW010365NIAID NIH HHS F31 AI150029NIAID NIH HHS U19 AI089674
6 · The paper itself

Abstract

The scale-up of malaria control efforts has led to marked reductions in malaria burden over the past twenty years, but progress has slowed. Implementation of indoor residual spraying (IRS) of insecticide, a proven vector control intervention, has been limited and difficult to sustain partly because questions remain on its added impact over widely accepted interventions such as bed nets. Using data from 14 enhanced surveillance health facilities in Uganda, a country with high bed net coverage yet high malaria burden, we estimate the impact of starting and stopping IRS on changes in malaria incidence. We show that stopping IRS was associated with a 5-fold increase in malaria incidence within 10 months, but reinstating IRS was associated with an over 5-fold decrease within 8 months. In areas where IRS was initiated and sustained, malaria incidence dropped by 85% after year 4. IRS could play a critical role in achieving global malaria targets, particularly in areas where progress has stalled.

Indexed as

InsecticidesAnimalsAnophelesEpidemiological MonitoringGeographyHumansIncidenceMalariaMosquito ControlMosquito VectorsUgandaInsecticides

Identifiers

PMID33976132
PMCPMC8113470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.